Cisbio Bioassays

Cisbio Bioassays is a global developer of technologies that are used in assay development and drug screening. Cisbio pioneered the field of homogenous fluorescence methodologies via its proprietary technology, HTRF®, a highly sensitive, robust technology for the detection of molecular interactions and widely used by the pharmaceutical industry in HTS. Tag-lite®, a complete technology, reagent and service platform, was launched in 2009 for the investigation of receptor and cell surface biomolecule biology, and to streamline drug discovery for these targets. Cisbio is focusing its innovation efforts on tailoring this new platform to both small molecule and biotherapeutic screening. In the biotherapeutic research field, HTRF®, and Tag-lite® technological platform in particular, is showing multiple advantages over conventional technologies to screen, characterize and investigate mode of actions of drug candidates. Cisbio Bioassays has developed a full range of biomolecular and cellular tools to tackle cell surface receptor targets, such as GPCRs, RTKs, and potentially other elements at the cell membrane. Theses toolboxes enable a rapid and flexible assay development process by researchers, as well as a streamlined and reproducible implementation for the purpose of biotherapeutic screening and characterization. This reagent offer is also completed by a full range of services, driven by a team of dedicated specialists, allowing scientists to have access to reagents customized to their target of choice in full confidentiality, and in a cost effective way.